9
This’ll bend your curve: Promising new anti-cholesterol drugs may cost $10K/yr. Will O’care cost-cut board approve? nyti.ms/1GwX2Lm
Mickey Kaus
Kausfiles
This’ll bend your curve: Promising new anti-cholesterol drugs may cost $10K/yr. Will O’care cost-cut board approve? nyti.ms/1GwX2Lm
@kausmickey Not directly to your point, but I hope they’re not approved until the completion of the clinical trials. On cost, if the trials
@kausmickey show a dramatically greater impact on heart disease than statins, that’ll open up a huge cost concern. Otherwise, especially
@kausmickey given that it needs to be injected, limiting its use shouldn’t be too controversial. $50bn/yr gross seems doable.